The HIV Workforce Survey Is Open
Have you had problems accessing and completing the HIV Workforce Survey? If so, you're not the only one who has experienced this issue. A technical glitch caused the site to tell some people that the survey is closed. But the survey is still open and we want you to take it.
In This Issue
This week we deepen the dialogue about the Mississippi baby supposedly "cured" of HIV. Here we consider the back story that would result in a mother not receiving prenatal care and learning that she was HIV-positive during her delivery. What went wrong? And what are the implications for ending the epidemic?
Falling Out of Care and Black Women's Access to HIV/AIDS Treatment
The second in a series examining the reports of a pediatric "functional cure" and its implications across Black America. In Part 1 we asked whether a Mississippi infant supposedly cured of HIV actually had the virus at all.
Read more: Falling Out of Care and Black Women's Access to HIV/AIDS Treatment
Medicaid Expansion Will Open Doors To Care for Ex-Convicts
Newly freed prisoners traditionally walk away from the penitentiary with a bus ticket and a few dollars in their pockets. Starting in January, many of the 650,000 inmates released from prison each year will be eligible for something else: health care by way of Medicaid, thanks to the Affordable Care Act.
Read more: Medicaid Expansion Will Open Doors To Care for Ex-Convicts
NIH Scientists, Grantees Map Possible Path to an HIV Vaccine
Co-Evolution of HIV and Strong Antibody Response Charted for First Time
WHAT:
In an advance for HIV vaccine research, scientists have for the first time determined how both the virus and a resulting strong antibody response co-evolved in one HIV-infected individual. The findings could help researchers identify which proteins to use in investigational vaccines to induce antibodies capable of preventing infection from an array of HIV strains. Previously, a study of antibody genetics enabled scientists to deduce the step-by-step evolution of certain broadly neutralizing antibodies—those that can prevent infection by the majority of HIV strains found around the globe. Yet the specific viruses that gave rise to those antibodies and the virus mutations that drove them to reach their final form remained unknown, hampering HIV vaccine discovery.
Read more: NIH Scientists, Grantees Map Possible Path to an HIV Vaccine